Companies: 10,795·Total market cap: $144.5T
MediPharm Labs Corp.

MediPharm Labs Corp.

LABS.TOTSXHealthcare● Active
$0.07
$-0.01(-6.67%)
Market Cap$29740480
P/E Ratio
52W High$0.1
52W Low$0.06
Overview

MediPharm Labs Corp. (LABS.TO) Stock Overview

Key statistics and deep links to earnings, valuation, revenue, dividends, and more.

FMP · LABS.TO · as of Jun 8, 2026

Key Statistics

EPS (TTM)$-0.02labs.to eps ttm · labs.to earnings per shareEarnings history
PE Ratio (TTM)labs.to pe ratio ttm · labs.to price to earningsPE Ratio deep dive
Revenue (TTM)$43.3Mlabs.to revenue ttm · labs.to annual revenueFull revenue history
Dividend YieldNo Dividenddoes labs.to pay dividends · labs.to dividend yieldDividend history
Shares Outstanding420.8Mlabs.to shares outstanding · labs.to floatShares outstanding history
Next EarningsAug 13, 2026Est.labs.to earnings date · labs.to next earningsEarnings history

Financial Snapshot

Full Financials
FY 2025Revenue$45.1M▲ +7.54% YoY
202320242025
medipharm labs corp. revenue · labs.to revenue 2025
FY 2025Net Income-$8.3M▲ +22.69% YoY
202320242025
medipharm labs corp. net income · labs.to profit 2025
FY 2025EPS$-0.02▲ +25.19% YoY
202320242025
labs.to eps · medipharm labs corp. earnings per share 2025
TTM:Revenue: $43.3MNet Income: -$8.7MEPS: $-0.02View income statement →

Stock Performance

Full History
1D-6.67%
1W-12.50%
1M-17.65%
3M+7.69%
YTD+7.69%
1Y-12.50%
5Y-85.57%

About MediPharm Labs Corp.

CEOGreg Hunter
IPO DateMar 4, 2019
Employees161
CountryCA

MediPharm Labs Corp. a pharmaceutical company, produces and sells pharmaceutical-quality cannabis oil and concentrates, and advanced derivative products in Canada, Australia, Germany, and internation…

what is medipharm labs corp. · labs.to stock overview · medipharm labs corp. company profile · who is medipharm labs corp. ceo · labs.to TSX · medipharm labs corp. headquarters · medipharm labs corp. business segments

About Stock Overview & Key Data

MediPharm Labs Corp. (LABS.TO) is a Healthcare company in the Drug Manufacturers - Specialty & Generic industry, listed on TSX since Mar 4, 2019. As of the latest trading session, LABS.TO stock price is $0.07, with a market capitalization of $29.7M. The stock has returned -12.50% over the past 12 months and +7.69% year-to-date.

In fiscal year 2025, MediPharm Labs Corp. reported revenue of $45.1M. For detailed financial data including revenue history, earnings, and balance sheet — use the tabs above.

Frequently Asked Questions

As of the latest trading session, MediPharm Labs Corp. (LABS.TO) stock price is $0.07. The stock is traded on TSX under the ticker symbol LABS.TO. The 52-week range is $0.06 – $0.10.

LABS.TO stock priceLABS.TO quote todaylive ticker
Data provided by Financial Modeling PrepLast updated: Jun 8, 2026Not investment advice